HE4, yamamotoM

HE4, yamamotoM - HE4, yamamotoM

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043062

Enrollment

Registered

2021-01-20

Start date

2017-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dilated cardiomyopathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: DCM

Exclusion criteria

Exclusion criteria: Tumor-bearing and HD

Design outcomes

Primary

Measure	Time frame
The study endpoint was a composite of all-cause death, left ventricular assist device (LVAD) implantation, and hospitalization for HF events. Furthermore, composite of all-cause death and LVAD implantation were defined as hard endpoint.	—

Countries

Japan

Contacts

Public ContactShinsuke Hanatani

Kumamoto University Department of Cardiovascular Medicine, Faculty of Life Sciences

s-hanata@kumamoto-u.ac.jp+81963735175

Outcome results